Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
7.68
-0.03 (-0.39%)
At close: Feb 3, 2026, 4:00 PM EST
7.60
-0.08 (-1.04%)
After-hours: Feb 3, 2026, 5:44 PM EST
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.07 billion as of February 3, 2026. Its market cap has decreased by -22.80% in one year.
Market Cap
1.07B
Enterprise Value
662.14M
1-Year Change
-22.80%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.07B, a decrease of -30.34%. That is a compound annual growth rate of -5.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 1.07B | 27.86% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.13B |
| Septerna | 1.12B |
| EyePoint | 1.10B |
| ORIC Pharmaceuticals | 1.09B |
| Phathom Pharmaceuticals | 1.08B |
| AbCellera Biologics | 1.05B |
| Iovance Biotherapeutics | 1.04B |
| CytomX Therapeutics | 1.03B |